Relief Therapeutics Holding SA Stock OTC Markets
Equities
RLFTY
US7595JP3044
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.401 USD | -2.06% | 0.00% | -33.30% |
Mar. 22 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Mar. 22 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2021 | 3.32 | Sales 2022 | 6.08 | Capitalization | 132M |
---|---|---|---|---|---|
Net income 2021 | -34M | Net income 2022 | -50M | EV / Sales 2021 | 70,411,981 x |
Net cash position 2021 | 40.5M | Net cash position 2022 | 14.89M | EV / Sales 2022 | 19,251,190 x |
P/E ratio 2021 |
-6.44
x | P/E ratio 2022 |
-2.5
x | Employees | 69 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.87% |
1 day | -2.06% | ||
Current month | -9.99% | ||
1 month | -9.99% | ||
3 months | -38.30% | ||
6 months | -42.20% | ||
Current year | -33.30% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | - | 22-01-27 |
Jeremy Meinen
DFI | Director of Finance/CFO | - | - |
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 46 | 16-05-24 |
Paolo Galfetti
COO | Chief Operating Officer | - | 21-05-26 |
Thomas Plitz
BRD | Director/Board Member | 56 | 20-12-16 |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+48.37% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- RLF Stock
- RLFTY Stock